NYSE:BIOLife Sciences
How Investors May Respond To Bio-Rad Laboratories (BIO) Facing Elliott’s Activist Push Over Sartorius Stake
On May 18, 2026, Elliott Investment Management disclosed a significant stake in Bio-Rad Laboratories and began pressing the company to address what it describes as prolonged share price underperformance since late 2021.
A central focus of Elliott’s campaign is Bio-Rad’s multibillion-dollar ownership stake in Sartorius, which it argues could be used more effectively to enhance shareholder value.
We’ll now look at how Elliott’s activist involvement, particularly around Bio-Rad’s Sartorius...